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Abstract
BACKGROUND: The purpose of this study was to set up nor-
mal values of the fractional uptake (FU) of technetium-99m
dimercaptosuccinic acid in adults and in the pediatric popula-
tion, as well as to evaluate the validity of this parameter at dif-
ferent levels of renal function.
MATERIAL AND METHODS: A total of 86 subjects was divided
into seven groups. In group A there were 23 potential kidney
donors and in group B, 18 children in remission after a first uri-
nary tract infection. Another three groups consisted of patients
with diabetes i.e. group C, seven patients with normal values of
albuminuria, group D, 16 patients with microalbuminuria and
group E, five patients with macroalbuminuria. In group F, there
were ten patients with a well-functioning transplanted kidney and
in group G, seven patients with suspected acute rejection. The
procedure began with the quantification of the doses of
99mTc-DMSA to be injected and the measurement of the empty
syringe lying on the gamma camera collimator. Thereafter, four
planar views of the kidneys were acquired three hours after the
injection. The counts from the posterior and anterior views were
subtracted for background and corrected for radioactive decay
time and patient thickness. The FU was calculated by the geo-
metric mean of counts per second from the posterior and anteri-
or view. It was expressed as a fraction of the injected dose.
RESULTS: The mean values of FU in healthy adults were 0.227 ±
± 0.077 for one kidney and 0.454 ± 0.146 for both kidneys.
The mean values of FU for the left and right kidney were 0.225 ±
± 0.071 and 0.229 ± 0.079, respectively. In children, the mean
values were 0.220 ± 0.092 for one kidney and 0.432 ± 0.094
for both kidneys. The highest values of FU of 0.322 ± 0.078
(0.644 ± 0.138 for both kidneys) were measured in group C. In
group D, FU was 0.185 ± 0.065 (0.361 ± 0.125 for both kid-
neys) and in group E 0.082 ± 0.040 (0.163 ± 0.080 total). In
patients with a transplanted kidney, fractional uptake was 0.162 ±
± 0.039 in group F and 0.065 ± 0.021 in group G. There was
no significant difference in the values of FU between healthy
adults and children. The uptake in group C was 41% higher
than in group A and the difference was statistically significant.
In groups D and E, the uptake was significantly lower than in A.
In both groups of patients with transplanted kidneys, the up-
take was significantly lower than in control group. The correla-
tion between FU and biochemical parameters of renal function
[blood urea nitrogen (BUN), serum creatinine (Cr) and creati-
nine clearance (CCr)] was significant: FU/BUN r = –0.86; FU/Cr
r = –0.77; FU/CCr r = 0.60.
CONCLUSION: Fractional uptake of 99mTc-DMSA could serve
as a sensitive parameter of renal function. The mean values of
FU in adults were 0.454 and in children 0.432. There was no
significant difference between values for the left and right kid-
ney. In diabetes mellitus, fractional uptake correlated well with
the degree of diabetic nephropathy. In patients with a well-func-
tioning transplant, the uptake was slightly reduced. Low values
of fractional uptake in acute rejection were related to lesions in
kidney blood vessels and in tubular cells.
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Introduction
Labeled dimercaptosuccinic acid (DMSA) has been in use for
more then thirty years for imaging the renal parenchyma, renal
anatomy, kidney size, position and shape. It has become the ra-
diopharmaceutical of choice for static renal scintigraphy and the
estimation of functioning renal mass, due to its particular uptake
in the renal cortex [1].
The uptake of DMSA in the kidney is the result of the complex
interaction of glomerular filtration, peritubular uptake and tubular
secretion. This diverse process is sometimes called tubular fixa-
tion. The extraction of DMSA from the peritubular extracellular flu-
id into the tubular cells remains, however, the main route of renal
handling [2]. Despite the slow transfer of DMSA from the blood to
the kidney, about 50% of the injected activity is taken up within
one hour after injection.
Relative right to left kidney uptake of DMSA is a very good
indicator of differential function of proximal part of the tubuli and
loops of Henley. A more comprehensive renal evaluation, includ-
ing individual kidney cortical function can be obtained by calcula-
tion of fractional uptake of DMSA in the kidneys [3]. Quantification
of kidney uptake is applied in the measurement of residual renal
function, for serial measurements of renal function when some
intervention is planned or to monitor renal function in order to de-
tect progressive loss of function [4].
The purpose of this study was to set up the normal values of
fractional uptake in adults and in the pediatric population, in order
to use this parameter routinely in assessing renal function. Fur-
thermore, the sensitivity of FU at different levels of renal function
impairment was evaluated in patients with native kidneys and those
with kidney transplants.
Material and methods
The investigation was carried out in 86 subjects: 68 adults
(33 males and 35 females, mean age 39.6 ± 10.5) years and 18 chil-
dren (6 boys and 12 girls, mean age 10.1 ± 2.5 years). According
to the clinical diagnosis and the degree of renal function impair-
ment, they were divided into seven groups. The first two groups
consisted of healthy individuals. The population of potential kid-
ney donors was used to establish the group of healthy adults. The
selection for the control group of children was made among pedi-
atric patients in remission after a first urinary tract infection. DMSA
renal scans of these individuals were made and two independent
observers classified them as normal and abnormal. 23 normal
scintigrams of adults were used for group A and 18 normal scin-
tigrams of children were selected for group B. All patients of these
two groups underwent ultrasound examination and no pathologi-
cal finding was revealed.
In another three groups where patients had diabetes: group C
consisted of seven patients with normal values of albuminuria (less
than 7 mg/day), group D of 16 patients with microalbuminuria and
group E of 5 patients with clinically detectable proteinuria (more than
500 mg/day). The two last groups consisted of patients with trans-
planted kidney: group F of 10 patients with well-functioning trans-
plant and group G of 7 patients with suspected acute rejection.
In all patients, blood urea nitrogen (BUN), serum creatinine
(Cr) and creatinine clearance (CCr) were measured 24 hours be-
fore scintigraphy.
For the estimation of creatinine clearance, urine was collect-
ed over 24 hours. The following equation was used:
Creatinine cearance [ml/min] =
where:
Ucr — urinary creatinine concentration,
Q — volume of urine in 24 h,
Pcr — serum creatinine concentration.
Values of creatinine clearance in children were normalized to
1.73 m2 of body surface. Patients were hydrated prior the exami-
nation with 10 ml of fluid per kilogram of body weight.
99mTc-DMSA preparation: DMSA was provided in a commer-
cial kit form (Institute for Nuclear Science “Vinca”, Belgrade, Ser-
bia) and stored at 4°C. Each vial contained 2 mg DMSA and
0.8 mg SnCl2 in a lyophilized form. The 
99mTc generator (Institute
for Nuclear Science “Vinca”, Belgrade) was eluted into three ali-
quots and 740 MBq from the second one was added to the kit.
The total volume of reconstituted 99mTc-DMSA was made up to
5 ml with normal saline. The 99mTc-DMSA was kept at room tem-
perature and injected between 30 and 60 min after preparation.
The standard dose for a 70-kg adult was 100 MBq. In children,
the doses where adjusted to the age and weight, according to the
recommendations of Pediatric Task Group of EANM. The minimal
activity injected was 20 MBq.
Data acquisition: Acquisition was performed on a single-head-
ed gamma camera Orbiter ZLC 3700 (Siemens, Erlangen, Germa-
ny), equipped with low-energy, high resolution collimator. The dose
syringe was counted on gamma camera face for one minute be-
fore and after the injection. The exact times when countings were
performed were noted. In all patients, extravasations of the tracer
at the injection site were excluded. Static renal scintigraphy was
done 3 hours after the injection. With the patient lying supine on the
bed, four images were taken: posterior, anterior, left lateral, right
lateral. Lateral views were recorded for the measurement of total
body-part thickness. Images were collected in a 256 × 256 resolu-
tion matrix with 600 kcounts acquired.
Background correction: C-shaped regions of interest, out-
lined above the superior, lateral and inferior aspects of the kidney
were used for the subtraction of background.
Calculation of 99mTc-DMSA fractional uptake: Fractional up-
take was calculated by “conjugate-view method”, which uses the
geometric mean of counting rates from the posterior and the an-
terior view, as well as the patient’s total body-part thickness. Phys-
ical decay of 99mTc and soft tissue attenuation were also taken into
account. The following formula was used:
FU =
where:
D1 — activity of syringe + dose (counts/second),
D2 — activity of empty syringe (counts/second),
D = (D1 – D2) — injected activity (counts/second),
C1 — background subtracted counts per second from the pos-
terior view of kidney,
C2 — background subtracted counts per second from the ante-
rior view of kidney,
(C1 × C2) × e
T × ln 2
1
2
× e
m × L
21
D1 – D2
t
Ucr [mg%] × Q [ml]
Pcr [mg%] × 1440 [min]
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T — time interval (scan time minus injection time),
t — half-life of 99mTc,
m — linear attenuation coefficient of 99mTc,
L — total body-part thickness
Attenuation coefficient for 99mTc was measured using Perspex
phantom and found to be 0.122 cm-1.
FU was expressed as a fraction of the injected activity.
For statistical analysis of the obtained data, the usual meth-
ods of descriptive and inferential statistics were used. Fractional
uptake was reported as mean (± SD) values. The differences
between the renal uptake rates in different groups of patients were
evaluated using Student’s t-test. P-values less than 0.05 were
considered statistically significant. In addition, linear regression
analysis was performed, by means of regression equation and
correlation coefficient calculation.
Results
Figures 1–3 display absolute mean kidney uptakes in all
86 subjects (157 kidney units). The mean values of FU in healthy
adults were 0.227 ± 0.077 for one kidney and 0.454 ± 0.146 for
both kidneys. For the left kidney, the mean values were 0.225 ±
± 0.071 and for the right kidney 0.229 ± 0.079. In children, the
mean values were 0.220 ± 0.092 for one kidney and 0.432 ± 0.094
for both kidneys. There was no significant difference in the values of
fractional uptake between healthy adults and children (p > 0.05).
The highest values of FU of 0.322 ± 0.078 (0.644 ± 0.138 global)
were measured in diabetic patients without albuminuria (C). In group
D, the mean values of FU were 0.185 ± 0.065 (0.361 ± 0.125 glo-
bal) and in group E 0.082 ± 0.040 (0.163 ± 0.080 global). The up-
take in group C was 41% higher than in group A, 78% higher than in
D and four times higher than in E. In group D, FU was 18% lower than
in A. Group E showed 64% lower values than in A and 55% lower
values than in D. In patients with well-functioning transplants, the up-
take was 0.162 ±  0.039. These values were 28% lower than in group
A. The lowest FU values of 0.065 ± 0.021 were measured in group of
patients with acute rejection (G). The values in this group were 71%
lower than in group A and 60% lower than in group F. There was no
overlap between groups F and G: the highest value in group G of
0.095 was lower than the lowest values in group F of 0.110.
The correlation between fractional uptake and biochemical
parameters of renal function was significant. Negative correlation
was obtained between blood urea nitrogen and uptake of 99mTc-
DMSA (r = –0.86), as well as between serum creatinine and up-
take of 99mTc-DMSA (r = –0.77). The correlation between creati-
nine clearance and FU was positive (r = 0.60).
Discussion
There were two control groups in our study. We used the pop-
ulation of potential kidney donors and those with normal values of
relevant biochemical tests and normal findings on renal ultrasound
and DMSA scintigraphy were selected for the control group of
adults. Similarly, the pediatric patients in remission after a first
urinary tract infection with normal ultrasound and DMSA renal scin-
tigrams made a control group for the child population.
We measured kidney uptake of DMSA three hours after the
injection, due to the heavy workload in our very busy department.
Figure 3. Tc-99m DMSA uptake in groups of patients with transplanted
kidney: comparison with one kidney uptake in control group.
Figure 1. Tc-99m DMSA fractional uptake of left kidney, right kidney and
total in healthy adults (A) and healthy children (B).
Figure 2. Tc-99m DMSA uptake of one kidney and total uptake in patients
with diabetes mellitus: comparison with control group.
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Although the uptake increases continuously after three hours and
reaches plateau between six and eight hours, the difference be-
tween three and six hours uptake is just about 4% [5].
The handling of DMSA by the kidneys depends on a function-
ing renal cortical mass and cortical perfusion. Thus, renal cortical
uptake of DMSA, expressed as a fraction of the administered dose
reflects individual renal function [6].
Among several methods that have been established for kid-
ney uptake quantification, the “conjugate view” represents plausi-
ble compromise between simplicity and accuracy [7]. This meth-
od is little more elaborate due to additional anterior view of kid-
neys, but should be applied when the difference in radiation at-
tenuation is expected, especially in cases with an anatomical ab-
normalities of the kidney.
The values of FU obtained in our study were in accordance
with the results of other authors. Murase et al. who also applied
the conjugate view method [8] measured one kidney uptake with
a mean value of 0.228 ± 0.074. The results of Zananiri et al. [9] of
0.254 ± 0.089 were higher in comparison with ours, but the meth-
od applied took kidney thickness into account and was much more
elaborate. Gordon et al. [10] measured six hour DMSA uptake in
healthy children and obtained the values of 0.441 for both kid-
neys. Tsukamoto et al. [11] reported normal values of fractional
uptake in a pediatric population: 0.407, 0.202 and 0.204 for both
kidneys, right and left kidneys, respectively. The results of Gordon
et al. [10] and Tsukamoto et al. [11] were comparable with our
values of three hour uptake in a group of healthy children.
In patients with diabetes, absolute uptake was in a significant
correlation with the degree of diabetic nephropathy. Diabetic pa-
tients with normal values of albuminuria showed significantly higher
FU in comparison with the control group. This could be a result of
renal vasodilatation and subsequent hyperperfusion, due to neu-
rohumoral changes that occur in diabetes (decreased plasma
rennin activity and angiotensin II levels, diminished response to
angiotensin II and norepinefrin, increased production of prostag-
landins and glucagon and extracellular volume expansion) [12].
In patients with microalbuminuria, values of FU were significantly
lower than in the control group. The deterioration of FU is proba-
bly due to the narrowing of the afferent and efferent arterioles. In
patients with macroalbuminuria, extensive tubulointerstitial chang-
es (tubular atrophy, interstitial fibrosis) are responsible for pro-
gressive decrease of renal DMSA uptake.
In patients a with well-functioning transplanted kidney, the
uptake was slightly reduced, probably due to an acute tubular
lesion, which is common in the early post transplantation period,
particularly in cadaver kidney grafts. The patients with acute re-
jection of transplanted kidney showed low values of fractional
uptake. This finding is probably caused by the extensive patho-
logical changes of kidney blood vessels, and tubular cells [13].
The results of our study confirmed that the estimation of the
fractional uptake of 99mTc-DMSA gives additional quantitative in-
formation on cortical and renal mass function. Besides its well-
established usefulness in follow-up of children at risk for progres-
sive renal damage and in the measurement of renal function prior
an intervention, FU estimation could be performed as a part of a
majority of 99mTc-DMSA studies. The individual and global specif-
ic uptake of 99mTc-DMSA could also help to assess renal function
impairment in diabetes mellitus, as well as in kidneys at early post-
transplantation period.
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